v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Net loss including redeemable non-controlling interests $ (565) $ (1,368) $ (468)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 509 369 156
Stock-based compensation 1,088 889 486
Reduction of operating lease right-of-use assets and accretion of operating lease liabilities 108 81 52
Adjustments to non-marketable equity securities, including impairment, net 101 303 0
Other 15 20 75
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:      
Funds held at payment processors 86 (86) (174)
Accounts receivable, net (141) (33) (94)
Prepaid expenses and other current assets (105) (165) 85
Other assets (96) (90) (51)
Accounts payable 70 (15) 79
Accrued expenses and other current liabilities 702 566 595
Payments for operating lease liabilities (113) (75) (44)
Other liabilities 14 (29) (5)
Net cash provided by operating activities 1,673 367 692
Cash flows from investing activities      
Purchases of property and equipment (123) (176) (129)
Capitalized software and website development costs (201) (170) (108)
Purchases of marketable securities (1,946) (1,948) (2,344)
Sales of marketable securities 7 387 224
Maturities of marketable securities 1,940 1,552 720
Purchases of non-marketable equity securities (17) (15) (409)
Net cash acquired in acquisitions 0 71 0
Other investing activities (2) (1) (1)
Net cash used in investing activities (342) (300) (2,047)
Cash flows from financing activities      
Proceeds from exercise of stock options 6 11 32
Deferred offering costs paid 0 0 (10)
Repayment of convertible notes 0 0 (333)
Taxes paid related to net share settlement of equity awards 0 0 (172)
Repurchase of common stock (750) (400) 0
Other financing activities (8) 14 0
Net cash used in financing activities (752) (375) (483)
Foreign currency effect on cash, cash equivalents, and restricted cash 5 (10) (1)
Net increase (decrease) in cash, cash equivalents, and restricted cash 584 (318) (1,839)
Cash, cash equivalents, and restricted cash, beginning of period 2,188 2,506 4,345
Cash, cash equivalents, and restricted cash, end of period $ 2,772 $ 2,188 $ 2,506